All are causes of mechanical intestinal obstruction except which of the following?
Most important early postoperative complication of ileostomy:
A 50-year-old patient with renal insufficiency was recently operated on for pyelolithotomy. Which drug is the most appropriate choice for post-operative analgesia?
Which of the following is not a prokinetic?
What is the treatment of choice for a post-operative abscess?
In surgical stress all hormones are increased except:
Following complete ileal and partial jejunal resection, the patient is most likely to have-
Which Benzodiazepine decreases post-operative nausea & vomiting:-
A meta-analysis comparing ERAS versus traditional perioperative care shows 30% reduction in length of stay and 50% reduction in complications without increase in readmission rates. However, implementation costs are 20% higher initially. As a department head, how should you evaluate the adoption of ERAS protocol?
A hospital is designing an ERAS protocol for gynecological oncology surgery. Literature shows conflicting evidence about routine nasogastric tube (NGT) placement versus no NGT. Considering ERAS principles and risk-benefit analysis, which approach would be most appropriate and why?
Explanation: ***Mesenteric vascular occlusion*** - This condition causes **ischemic bowel injury** due to impaired blood flow, leading to **paralytic ileus** rather than a physical blockage. - While it results in intestinal dysfunction, it does not involve a **mechanical obstruction** by a physical barrier. *Gall stones* - Large **gallstones** can erode through the gallbladder wall into the small intestine, leading to a condition called **gallstone ileus**. - This creates a **physical obstruction** within the lumen of the small bowel. *Intussusception* - **Intussusception** involves one segment of the intestine telescoping into an adjacent segment. - This creates a **mechanical blockage** of the intestinal lumen. *Bands* - Internal **fibrous bands** or adhesions, often from previous surgeries, can constrict and obstruct the bowel lumen. - These bands represent a direct **physical impediment** to the passage of intestinal contents.
Explanation: ***Necrosis*** - Stomal **necrosis** can occur early postoperatively due to issues with **blood supply** to the ileum, often caused by excessive tension on the mesentery or improper creation of the stoma. - This complication can lead to severe issues like perforation and sepsis if not promptly identified and managed. *Obstruction* - While **obstruction** can occur after ileostomy, it is typically a **delayed complication** often caused by adhesions, internal herniation, or food bolus impaction. - Early postoperative obstruction is less common unless there's an immediate surgical issue like a twisted loop or stricture. *Prolapse* - **Stoma prolapse**, where the bowel telescopes out through the stoma, is usually a **late complication** that develops over time due to weakened abdominal wall muscles or increased intra-abdominal pressure. - It is rarely seen in the immediate postoperative period without predisposing factors. *Diarrhea* - **High-output stoma** (sometimes referred to as diarrhea in general terms) is a common early postoperative issue, but it is considered a **physiological response** rather than a complication. - This is due to the lack of colonic absorption, leading to unformed stools and potential electrolyte imbalances, but it's not a direct surgical complication in the same way necrosis is.
Explanation: ***Acetaminophen*** - **Acetaminophen** is primarily metabolized in the liver, with minimal renal excretion, making it a safer option for patients with **renal insufficiency**. - It provides effective **analgesia** without the adverse renal effects associated with NSAIDs. *Diclofenac sodium* - **Diclofenac** is a non-steroidal anti-inflammatory drug (**NSAID**) that can impair renal function, especially in patients with pre-existing **renal insufficiency**, by inhibiting prostaglandin synthesis. - Its use can lead to further **kidney damage** or exacerbate existing renal impairment. *Naproxen* - **Naproxen** is an **NSAID** that carries a significant risk of causing acute kidney injury in patients with **compromised renal function**. - It reduces renal blood flow and glomerular filtration rate, making it unsuitable for this patient. *Indomethacin* - **Indomethacin** is a potent **NSAID** known for its adverse renal effects, including acute renal failure. - It should be avoided in patients with **renal insufficiency** due to its potential to further decline kidney function. *Ketorolac* - **Ketorolac** is a potent **NSAID** commonly used for post-operative pain but is **contraindicated** in patients with renal insufficiency. - It has significant nephrotoxic potential and can cause acute renal failure, especially in patients with pre-existing kidney disease.
Explanation: **Loperamide derivative** - **Loperamide** is an **opioid receptor agonist** that acts on the mu-opioid receptors in the gut, primarily to **decrease gastrointestinal motility** and treat diarrhea. - Its mechanism of action directly opposes that of prokinetic agents, which aim to increase GI motility. *Macrolides* - Certain macrolide antibiotics, particularly **erythromycin**, act as **motilin receptor agonists** at low doses. - This agonism leads to increased gastric motility and can be used as a prokinetic in conditions like gastroparesis. *D2 blocker* - **Dopamine D2 receptor antagonists** (e.g., **metoclopramide**, **domperidone**) block the inhibitory effect of dopamine on cholinergic smooth muscle. - This blockade enhances acetylcholine release, leading to increased gastrointestinal motility and prokinetic effects. *5HT4 agonist* - **Serotonin 5-HT4 receptor agonists** (e.g., **cisapride**, **prucalopride**) stimulate the release of acetylcholine and other excitatory neurotransmitters in the enteric nervous system. - This action promotes increased gastrointestinal motility, making them effective prokinetic agents.
Explanation: ***Image-guided aspiration*** - This is often the **first-line treatment** for a post-operative abscess, especially if it is well-localized. - It involves **draining the pus** under imaging guidance, relieving pressure and removing the infectious material. *Hydration* - While important for overall patient management, especially in cases of infection or sepsis, **hydration alone does not treat an abscess**. - It is a supportive measure but does not address the **localized collection of pus**. *IV antibiotics* - Antibiotics are typically indicated as an **adjunct to drainage**, especially in cases of systemic infection or cellulitis. - However, **antibiotics alone are often insufficient** to resolve an abscess as they have difficulty penetrating the necrotic core and thick capsule. *Reexploration* - **Surgical reexploration** is a more invasive option usually reserved for abscesses that are **large, multiloculated, not amenable to percutaneous drainage**, or when initial drainage attempts fail. - It carries greater risks and is not the initial treatment of choice for every post-operative abscess.
Explanation: ***Insulin*** - While other **stress hormones** increase, **insulin** levels typically **decrease** or remain stable due to increased **insulin resistance** during surgical stress. - This physiological response aims to maintain **blood glucose** levels for energy during heightened metabolic demands. *Epinephrine* - **Epinephrine** (adrenaline) is a key **catecholamine** released during surgical stress, leading to a "fight or flight" response. - It increases **heart rate**, **blood pressure**, and promotes **gluconeogenesis** to supply quick energy. *ACTH* - **Adrenocorticotropic hormone (ACTH)** is released from the **pituitary gland** in response to surgical stress. - **ACTH** stimulates the adrenal cortex to produce **cortisol**, a critical stress hormone. *Cortisol* - **Cortisol** levels significantly rise during surgical stress, mediated by **ACTH** release. - It plays a crucial role in **modulating inflammation**, **glucose metabolism**, and maintaining **hemodynamic stability**.
Explanation: ***Vitamin B12 Deficiency*** - The **terminal ileum** is the primary site for **vitamin B12 absorption**, complexed with intrinsic factor [3]. Resection of this segment significantly impairs this process. - Patients with **ileal resection** are highly susceptible to developing **megaloblastic anemia** and neurological complications due to **vitamin B12 deficiency** [3]. *Constipation* - Complete ileal and partial jejunal resection is **more likely to cause diarrhea** rather than constipation, particularly due to malabsorption of bile salts and fats [2]. - **Bile salt malabsorption** in the colon often leads to secretory diarrhea [1]. *Gastric ulcer* - Gastric ulcers are typically associated with *Helicobacter pylori* infection or NSAID use, and are **not a direct consequence** of ileal and jejunal resection. - While short bowel syndrome can sometimes lead to increased gastric acid secretion, peptic ulcer formation is not the most likely or direct complication. *Folic acid deficiency* - **Folic acid** is primarily absorbed in the **jejunum**, and while partial jejunal resection occurred, complete ileal resection is less directly implicated in folate deficiency. - Other sections of the small intestine can often compensate for partial jejunal loss in folate absorption, making B12 deficiency a more immediate and severe concern after complete ileal resection.
Explanation: ***Midazolam*** - **Midazolam** is a commonly used benzodiazepine in anesthesia that has been shown to have **antiemetic properties** and can decrease the incidence of **postoperative nausea and vomiting (PONV)**. - Its mechanism may involve its sedative and anxiolytic effects, indirectly reducing the triggers for nausea. *Diazepam* - While **diazepam** is a benzodiazepine with sedative and anxiolytic effects, it is not primarily known for reducing PONV. - Its longer duration of action compared to midazolam can also contribute to unwanted **postoperative sedation**. *Lorazepam* - **Lorazepam** is another benzodiazepine used for anxiolysis and sedation but is not a primary agent for the prevention of PONV. - Like diazepam, its prolonged effects can lead to **delayed recovery** and drowsiness, which may not be desirable in the postoperative period. *All of the options* - While all listed drugs are benzodiazepines, only **midazolam** is consistently recognized and utilized for its ability to reduce PONV in the perioperative setting. - The other benzodiazepines do not demonstrate the same consistent benefit in PONV reduction and may have other side effects that limit their utility for this specific purpose.
Explanation: ***Adopt ERAS based on superior clinical outcomes and likely long-term cost savings from reduced complications*** - Significant reductions in **length of stay (30%)** and **complications (50%)** provide strong evidence for the clinical superiority of **ERAS protocols** over traditional care. - The initial 20% cost increase is often offset by **long-term savings** gained from fewer hospital days and reduced management of postoperative complications. *Reject ERAS due to higher initial costs affecting hospital budget* - Focusing solely on **upfront costs** ignores the substantial economic benefit derived from **resource optimization** and beds being freed faster. - High-value healthcare prioritizes **outcomes per dollar spent**, and ERAS typically demonstrates a high **return on investment**. *Wait for more evidence before implementation* - Current **meta-analysis data** already provides high-level evidence regarding its efficacy in improving **surgical recovery**. - Delaying implementation based on sufficient existing evidence prevents patients from accessing safer, **evidence-based clinical pathways**. *Implement ERAS only for low-risk patients to minimize costs* - **ERAS protocols** are designed to be multi-modal and often provide the greatest absolute benefit to **high-risk patients** who are prone to complications. - Restricting the protocol limits the overall **scale of improvement** in hospital-wide metrics like **readmission rates** and total surgical volume.
Explanation: ***Selective NGT placement only for symptomatic patients with postoperative nausea/vomiting*** - **ERAS protocols** advocate against routine nasogastric decompression as it does not reduce the risk of **postoperative ileus** or **anastomotic leakage**. - Reserving **NGT placement** for patients who develop clinical symptoms like persistent vomiting or **gastric distension** minimizes risks and improves patient comfort. *Routine NGT placement as it prevents aspiration and monitors gastric output* - Studies show that routine usage actually increases **pulmonary complications** such as **pneumonia** and atelectasis due to interference with coughing. - It delays the return of **bowel function** and prolongs the time until a patient can tolerate an **oral diet**. *No NGT placement but prophylactic antiemetics to all patients* - While **prophylactic antiemetics** are a standard part of ERAS, this option incorrectly implies an absolute prohibition of NGT even when symptoms occur. - Clinical guidelines require the flexibility to use an **NGT as a rescue therapy** for patients with severe, refractory **gastric distension**. *NGT placement in all cases but removal within 6 hours postoperatively* - Even short-term placement can cause unnecessary **pharyngeal trauma** and severe **patient discomfort** during the immediate recovery phase. - Starting with an NGT in every patient contradicts the **evidence-based medicine** that suggests most oncology patients do not require decompression at all.
Get full access to all questions, explanations, and performance tracking.
Start For Free